Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Harding

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
JCO Precision Oncology|October 23, 2025
Intrahepatic Cholangiocarcinoma: Recurrence Patterns, Genomics, and SurvivalPratik Chandra, Yi Song, Esther Drill, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2015
Initial optimization and series evolution of diaminopyrimidine inhibitors of interleukin-1 receptor associated kinase 4W Michael Seganish, William T McElroy, R Jason Herr, et al.
Annals of Surgical Oncology|October 19, 2025
Outcomes of First Versus Second-Line Hepatic Artery Infusion Chemotherapy in Unresectable Intrahepatic CholangiocarcinomaNaaz Nasar, Misha Armstrong, Joanne F Chou, et al.
Journal of Hepatology|June 22, 2026
Hepatic artery infusion pump chemotherapy for unresectable intrahepatic cholangiocarcinoma: Pooled individual patient-level analysis of four clinical trialsMerve Rousian, Remo Alessandris, Lauren Schleimer, et al.
Hepatology (Baltimore, Md.)|March 25, 2021
Genetic Determinants of Outcome in Intrahepatic CholangiocarcinomaThomas Boerner, Esther Drill, Linda M Pak, et al.
Research Square|September 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II TrialWungki Park, Catherine O'Connor, Joanne Chou, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
JCO Precision Oncology|October 23, 2025
Intrahepatic Cholangiocarcinoma: Recurrence Patterns, Genomics, and SurvivalPratik Chandra, Yi Song, Esther Drill, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2015
Initial optimization and series evolution of diaminopyrimidine inhibitors of interleukin-1 receptor associated kinase 4W Michael Seganish, William T McElroy, R Jason Herr, et al.
Annals of Surgical Oncology|October 19, 2025
Outcomes of First Versus Second-Line Hepatic Artery Infusion Chemotherapy in Unresectable Intrahepatic CholangiocarcinomaNaaz Nasar, Misha Armstrong, Joanne F Chou, et al.
Journal of Hepatology|June 22, 2026
Hepatic artery infusion pump chemotherapy for unresectable intrahepatic cholangiocarcinoma: Pooled individual patient-level analysis of four clinical trialsMerve Rousian, Remo Alessandris, Lauren Schleimer, et al.
Hepatology (Baltimore, Md.)|March 25, 2021
Genetic Determinants of Outcome in Intrahepatic CholangiocarcinomaThomas Boerner, Esther Drill, Linda M Pak, et al.
Research Square|September 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II TrialWungki Park, Catherine O'Connor, Joanne Chou, et al.
Pageof 3